Literature DB >> 9605905

Reconsideration of rifampin: a unique drug for a unique infection.

D M Zavasky, M A Sande.   

Abstract

Mesh：

Substances：

Year:  1998        PMID： 9605905     DOI： 10.1001/jama.279.19.1575

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  15 in total

1.  CORR Insights®: Does Suture Type Influence Bacterial Retention and Biofilm Formation After Irrigation in a Mouse Model?

Authors:  Daniel J Stinner
Journal:  Clin Orthop Relat Res       Date:  2019-01       Impact factor: 4.176

2.  Transferrin iron starvation therapy for lethal bacterial and fungal infections.

Authors:  Lin Lin; Paul Pantapalangkoor; Brandon Tan; Kevin W Bruhn; Tiffany Ho; Travis Nielsen; Eric P Skaar; Yaofang Zhang; Ruipeng Bai; Amy Wang; Terence M Doherty; Brad Spellberg
Journal:  J Infect Dis       Date:  2014-01-19       Impact factor: 5.226

3.  Activity of Tedizolid in Methicillin-Resistant Staphylococcus epidermidis Experimental Foreign Body-Associated Osteomyelitis.

Authors:  Kyung-Hwa Park; Kerryl E Greenwood-Quaintance; Audrey N Schuetz; Jayawant N Mandrekar; Robin Patel
Journal:  Antimicrob Agents Chemother       Date:  2017-01-24       Impact factor: 5.191

4.  In vitro antimicrobial synergy testing of coagulase-negative staphylococci isolated from prosthetic joint infections using Etest and with a focus on rifampicin and linezolid.

Authors:  B Hellmark; M Unemo; A Nilsdotter-Augustinsson; B Söderquist
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-03-12       Impact factor: 3.267

5.  Unpredictable effects of rifampin as an adjunctive agent in elimination of rifampin-susceptible and -resistant Staphylococcus aureus strains grown in biofilms.

Authors:  Sander Croes; Patrick S Beisser; Cees Neef; Cathrien A Bruggeman; Ellen E Stobberingh
Journal:  Antimicrob Agents Chemother       Date:  2010-07-06       Impact factor: 5.191

6.  Linezolid alone or combined with rifampin against methicillin-resistant Staphylococcus aureus in experimental foreign-body infection.

Authors:  Daniela Baldoni; Manuel Haschke; Zarko Rajacic; Werner Zimmerli; Andrej Trampuz
Journal:  Antimicrob Agents Chemother       Date:  2008-12-15       Impact factor: 5.191

7.  Efficacy of linezolid plus rifampin in an experimental model of methicillin-susceptible Staphylococcus aureus endocarditis.

Authors:  Charlene F Dailey; Paul J Pagano; Lewis V Buchanan; Jennifer A Paquette; Joseph V Haas; John K Gibson
Journal:  Antimicrob Agents Chemother       Date:  2003-08       Impact factor: 5.191

8.  Factors associated with rifampin resistance in staphylococcal periprosthetic joint infections (PJI): a matched case-control study.

Authors:  Y Achermann; K Eigenmann; B Ledergerber; L Derksen; P Rafeiner; M Clauss; R Nüesch; C Zellweger; M Vogt; W Zimmerli
Journal:  Infection       Date:  2012-09-19       Impact factor: 3.553

9.  Simultaneous species identification and detection of rifampicin resistance in staphylococci by sequencing of the rpoB gene.

Authors:  B Hellmark; B Söderquist; M Unemo
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-08-21       Impact factor: 3.267

Review 10.  Colonization of medical devices by staphylococci.

Authors:  Yue Zheng; Lei He; Titus K Asiamah; Michael Otto
Journal:  Environ Microbiol       Date:  2018-05-06       Impact factor: 5.491
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.